We are live on ! Find out more
CNTX icon

Context Therapeutics
CNTX

24 hedge funds and large institutions have $4.59M invested in Context Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

20% more funds holding

Funds holding: 20 → 24 (+4)

3.06% more ownership

Funds ownership: 22.81% → 25.87% (+3.1%)

27% less capital invested

Capital invested by funds: $6.32M → $4.59M (-$1.73M)

Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$235K
2
ACM
AIGH Capital Management
Maryland
+$180K
3
Jane Street
Jane Street
New York
+$130K
4
Two Sigma Investments
Two Sigma Investments
New York
+$102K
5
QC
Quadrature Capital
United Kingdom
+$82.6K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$98K
2
AWS
Atria Wealth Solutions
New York
-$51K
3
UBS Group
UBS Group
Switzerland
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$1.43M +$180K +100,000 +8%
AAA
2
Affinity Asset Advisors
New York
$981K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$711K +$21.1K +11,720 +2%
WVP
4
Worth Venture Partners
New Jersey
$358K +$45K +25,016 +8%
KCM
5
Knoll Capital Management
Florida
$155K – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$145K +$235K +130,588 New
HighTower Advisors
7
HighTower Advisors
Illinois
$140K – – –
V
8
Veritable
Delaware
$122K – – –
S
9
swisspartners
Liechtenstein
$94K +$77K +42,765 +101%
Jane Street
10
Jane Street
New York
$80K +$130K +72,060 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$65K – – –
Two Sigma Investments
12
Two Sigma Investments
New York
$63K +$102K +56,531 New
QC
13
Quadrature Capital
United Kingdom
$51K +$82.6K +45,889 New
DCM
14
Difesa Capital Management
New York
$39K – – –
State Street
15
State Street
Massachusetts
$37K +$26.3K +14,607 +80%
TSS
16
Two Sigma Securities
New York
$28K +$44.7K +24,848 New
Northern Trust
17
Northern Trust
Illinois
$26K – – –
Morgan Stanley
18
Morgan Stanley
New York
$19K +$12.7K +7,057 +71%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$16K +$25.4K +14,137 New
Two Sigma Advisers
20
Two Sigma Advisers
New York
$15K +$24.1K +13,400 New
TRCT
21
Tower Research Capital (TRC)
New York
$8K +$7.8K +4,331 +146%
VF
22
Virtu Financial
New York
– -$98K -46,445 Closed
AWS
23
Atria Wealth Solutions
New York
– -$51K -24,000 Closed
UBS Group
24
UBS Group
Switzerland
– -$8K -3,627 Closed
Wells Fargo
25
Wells Fargo
California
– +$54 +30 +43%

CNTX Hedge Fund Activity: Q3 2022 in Review

24 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Context Therapeutics (CNTX) for Q3 2022, worth a combined $4.59M — down 27% from $6.32M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CNTX positions and 3 closed out — a net gain of 4 holders — while 8 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $235K. The largest seller was Virtu Financial, exiting entirely with an estimated $98K sold.

  • 24 institutional investors held Context Therapeutics (CNTX) as of Q3 2022, up from 20 in Q2 2022.
  • Funds reported $4.59M of Context Therapeutics stock for Q3 2022, down 27% quarter-over-quarter.
  • 7 funds opened new Context Therapeutics positions in Q3 2022 and 3 closed out, a net change of +4 holders.
  • The largest Context Therapeutics buyer in Q3 2022 was Renaissance Technologies, an estimated $235K added.
  • The largest Context Therapeutics seller in Q3 2022 was Virtu Financial, an estimated $98K sold.

Based on aggregated 13F filings for Q3 2022.